Cell-based therapy for neuropathic pain could provide analgesics to local pain modulatory regions in a sustained, renewable fashion. In order to provide enhanced analgesic efficacy, transplantable cells may be engineered to produce complementary or increased levels of analgesic peptides. In addition, genetic labeling of modified cells is desirable for identification and tracking, but it should be retained intracellularly as desired analgesic peptides are secreted. Usually constructs encode proteins destined for either extra-or intracellular compartments, as these pathways do not cross. However, interactions between intracellular destinations provide a window of opportunity to overcome this limitation. In this report, we have explored this approach using a potential supplementary analgesic peptide, [Ser 1 ]-histogranin (SHG), the stable synthetic derivative of a naturally occurring peptide with N-methyl D-aspartate (NMDA) antagonistic properties. A synthetic SHG gene was combined with (i) nerve growth factor-β (NGF-β) amino-terminal signal peptide to enable secretion, and (ii) a fluorescent cellular label (mRFP) with intervening cathepsin L cleavage site, and subcloned into a lentiviral vector. In addition, an endoplasmic retention signal, KDEL, was added to enable retrieval of mRFP. Using immunocytochemistry and confocal microscopic profile analysis, cells transduced by such lentiviruses were shown to synthesize a single SHG-mRFP polypeptide that was processed, targeted to expected subcellular destinations in several cell types. Dot blot and Western analysis revealed stable transduction and long-term secretion of SHG from PC12 cells in vitro. Transplantation of such cells provided modest analgesia in a rodent pain model consistent with low levels of SHG peptide in the cerebrospinal fluid (CSF). These results suggest that it is possible to deliver proteins with different final destinations from a single construct, such as pharmacologically active peptide for secretion and intracellular label for identifying transplantable cells.
INTRODUCTION
been promising, but variable (32) . It is likely that improved analgesic efficacy could be achieved by engineering transplantable cells to secrete novel and/or in-Transplantation of cells into the CNS can provide a constant and replenishable source of analgesic substances creased levels of synergistic analgesic peptides. A potentially promising target for enhancing analge-for alleviation of chronic pain. This cellular minipump approach has several potential benefits, such as long-sic activity is the NMDA receptor. Histogranin (HG) is a naturally occurring peptide with NMDA-antagonistic term delivery, reduced systemic side effects, and the ability to provide agents that would otherwise have lim-activity (23) . Its stable synthetic analog, [Ser 1 ]-histogranin (SHG), when administered intrathecally, blocks ited penetration past the blood-brain barrier. Further, cells can be combined or genetically manipulated to de- the hyperalgesia and allodynia produced in rats by intrathecal NMDA (18) . The SHG-mediated analgesia liver a therapeutic cocktail of multiple desired agents for synergistic effects or for treatment of chronic pain of may in part be mediated through its noncompetitive inhibition of NMDA/kainate subtype glutamate receptors different etiologies. Cell therapy using primary adrenal chromaffin cells from a variety of sources, as well as as well as tachykinin receptors (21, 34) . Furthermore, unlike prototypic NMDA antagonists, SHG does not have immortalized and tumor cell lines, has been attempted in several pain models with varying degrees of success attendant motor side effects (18, 21) . SHG was identified in a screen for compounds that enhanced adrenal trans- (32) . In addition, reports from experimental clinical studies using bovine and human chromaffin cells have plant-mediated analgesia in rat pain models (29) . SHG 446 GAJAVELLI ET AL.
has the potential to be delivered recombinantly on a long-BamHI-SalI fragment containing ppNGF-SHG-mRFP K-DEL was subcloned into lentiviral vector pRRL. term basis using emerging lentiviral technologies.
In order to identify cells containing a recombinant gene, typically a reporter gene such as enhanced green Generation of Lentiviruses and Infection of Cells fluorescent protein (EGFP) or "myc," can be inserted
The SHG construct in lentiviral vector pRRL and lendownstream and in frame with the gene of interest. tiviral packaging vectors were cotransfected into 293T Transcription of the recombinant DNA results in unique cells. The next day when the expression of the mRFP mRNA species that when translated results in a tagged could be seen, the culture was washed and supplemented or fluorescent fusion protein that can later be identified with fresh media. The p24 titer was assessed by p24 by immunofluorescence and staining with antibodies ELISA; the viral titer was determined by infecting cells. against either the protein itself of its "tag." This method Routinely titers of 10 7 -10 8 transducing agents/ml were can also be used to enrich transduced cell populations obtained. Cells that were to be infected with the virus for transplantation using FACS. However, fusion of were plated a day before the infection. After washing SHG with bulky EGFP would likely render it biologithe cells, high titer purified lentivirus was added to cells cally inactive due to its oligomerization. Thus, we have in fresh culture media at an MOI of 5 for 4 h. devised an approach that would enable unimpeded secretion of the antinociceptive peptides while also geneti-Immunocytochemistry and Antibodies cally tagging the secreting cells by creating a construct in which our gene of interest, SHG, and a modified Cells were fixed with 4% paraformaldehyde, perme-mRFP (monomeric red fluorescent protein), which does abilized with 0.1% Triton X-100, blocked with 10% nornot oligomerize (8), are separated by a dibasic residue mal goat serum, followed by primary antibodies: rabbit (KR) that is the substrate for cathepsin L (43) . In addianti-Giantin (1:500, Covance), rabbit anti-mRFP (1:1000, tion, an endoplasmic retention/retrieval signal (ER) Chemicon), rabbit anti-SHG (1:1000, 21st Century Bio-KDEL was added to enable retrieval of the mRFP. The chemicals), mouse anti-β-actin (1:100000) and mouse goal of this study was to develop and evaluate this stratanti-cytochrome c (1:1000, Sigma), mouse anti-human egy for use in potential transplantable cell sources. mitochondria (1:500), with mouse anti-Erd2 (1:500, Abcam and Stressgen). The Erd2 antibody staining was MATERIALS AND METHODS done in the presence of 0.2% Saponin (Sigma) as de-Cell Lines scribed previously (39) . Appropriate fluorescent secondary antibodies (1:200) were used (Molecular Probes). The cell lines utilized were 293T cells, PC12 cells, Cells were stained with 5 nM DAPI in the final wash to human bone marrow cells (41) , and cadaver-derived identify the nuclei. For dot blots and Western analysis marrow-isolated adult multilineage inducible (MIAMI) appropriate HRP conjugated secondary antibodies [1: cells (10) . 10000 goat anti-rabbit HRP (Santa Cruz); 1:5000 goat anti-mouse IgG-HRP (31)] were used.
Generation of Red SHG Construct
The SHG protein sequence was reverse translated and Culture Supernatants, Dot Blots, and Western Blots the resulting DNA sequences were used to synthesize oligos. Oligos were annealed in the presence of ligation Ten million naive or red SHG transduced PC12 cells were incubated in serum-free medium overnight (16 h). buffer; the double-stranded DNA (dsDNA) thus generated was flanked by BglII and XbaI to enable subcloning Cell culture supernatant was harvested by centrifugation and filtered through a 22-µm syringe; protein was esti-into ppNGF-β signal sequence containing vector digested with the same enzymes. The ppNGF-β signal mated and equal amounts of protein were used in blots. The dot blot protocol was adopted from Martin-Schild peptide enables production of secretable peptides and has been described elsewhere (13) . A PCR-based strat-et al. (25) . Briefly, a pair of PVDF membranes was wetted in methanol for 5 s, water for 2 min, and transfer egy was used to fuse the ppNGF-β-SHG cDNA in frame with mRFP cDNA (8). First, the ppNGF-SHG construct buffer for 5 min. The membranes are placed on two sheets of blotting paper presoaked in transfer buffer. Se-flanked by the BamHI site at the 5′ end was amplified with primers that remove the stop codon and introduce rial dilutions of the sample were prepared in a 96-well plate and placed in the wells. Vacuum was applied an XbaI site at the 3′ end. Second, the mRFP cDNA was amplified using primers that introduce an XbaI site at briefly and the topmost membrane was blocked overnight in 2% BSA, washed three times with TBST for 15 the 5′ end, a KDEL coding sequence, and a SalI site at the 3′ end. Both the PCR products were purified, di-min each, probed with appropriate dilution of the anti-SHG antibody for 45 min are room temperature, washed, gested with XbaI, subcloned, and sequenced. The and probed with secondary antibody. The blots are
The CSF was centrifuged at 1500 rpm for 5 min to pellet any red blood cells and stored at −20°C until assayed by washed again and developed with chemiluminiscent reagents (Perkin-Elmer).
dot blot or Western blot for SHG. Commercial gradient gels (4-20% acrylamide, Lifegels) were used with SeaBlue II protein ladder (In-RESULTS vitrogen) and electroblotted onto a PVDF membrane SHG-mRFP KDEL Construct (Immobilon PSQ; Millipore). Blots were processed using standard manufacturer's protocol and bands were A schematic in Figure 1a shows the design of the SHG-mRFP KDEL lentiviral construct. The cytomegalovi-detected with chemiluminiscence (Perkin-Elmer).
For densitometry, X-ray films with subsaturating rus (CMV) promoter drives expression of cDNA with prepro-nerve growth factor (ppNGF) signal peptide for chemiluminiscent signals were scanned using the BioRad FluorS scanner equipped with Quantity One software. A secretion; the interchangeable peptide cDNA is followed by mRFP with KDEL at the carboxy-terminus. Introduc-circle/band tool was used to draw contours around the signal; background was traced and their density deter-tion of KDEL at the carboxy-terminus is known to be sufficient for retrieval of proteins to endoplasmic reticu-mined and plotted. lum (ER). Interaction of KDEL receptor is optimal at Confocal Microscopy acidic pH [e.g., trans-golgi network (TGN)] (16, 28, 33) . Furin, a prohormone convertase responsible for cleavage Images were acquired using an LSM510 equipped Zeiss Confocal microscope at the Image Core. The "Pro-of the ppNGF signal peptide, is also active only in TGN at acidic pH. KDEL-tagged monomeric red fluorescent file" tool of LSM510 was used to quantitate fluorescence along a particular section of the image. A table protein (mRFP KDEL ) with a signal peptide has been used extensively and found to be localized to "vesicular" ER generated by the same tool was used to estimate the dimensions of SHG puncta.
in neurons and cell lines (1, 5, 24) . To test if the mRFP K-DEL generated for this study was also similarly distrib-Formalin Testing and Behavior uted, cells transduced with lentivirus and cell lysates prepared using nitrogen cavitation were imaged by con-In order to conduct an initial screen on the ability of transduced cells to release recombinant SHG and alter focal microscopy. Several red puncta with sizes ranging from 0.2 to >0.9 µm in diameter (n = 28) were observed pain sensitivity, a small group of animals was transplanted with either red SHG PC12 cells or control PC12 (Fig. 1b ). These puncta were intact following nitrogen cavitation (Fig. 1c ), a procedure routinely used to pre-cells (n = 6 per group). Cell suspensions were transplanted into the spinal subarachnoid space via laminec-pare intact vesicles and organelles (11, 15, 40) . To confirm the red puncta were indeed mRFP, lysates were tomy and a slit in the dura at the level of the lumbar enlargement (10 µl of 50,000 cells/µl) according to rou-analyzed by immunoblotting. Using anti-mRFP antibody, a band corresponding to 26 kDa ( Fig. 1d , upper panel) tine procedures in our laboratory. Animals received cyclosporine A (10 mg/kg, IP daily, beginning the day was detected only in the red SHG PC12 lysate (Fig. 1d , lane 2) but not in naive PC12 cell lysates (Fig. 1d , lane before transplantation surgery). At 1 week following transplantation, 50 µl of 5% formalin was injected in the 1). The blot was stripped and reprobed with anti-β-actin to normalize protein loading ( Fig. 1d , lower panel). plantar surface of one hind paw to elicit the formalin pain response. This results in typical biphasic formalin
To further assess localization of the mRFP KDEL , cells were stained with Erd2 (endoplasmic retrieval defective flinching response: phase 1, thought to be indicative of acute pain, occurring during the first minute postforma-2), a receptor for KDEL-tagged proteins, cytochrome c, a marker for mitochondria, and DAPI to visualize nuclei. lin; and phase 2, thought to result from central sensitization and indicative of tonic, more prolonged pain, sepa-Using Erd2 antibody, yellow bands suggesting points of interaction between mRFP KDEL and Erd2 were observed rated by a quiescent interphase between phase 1 and phase 2. The numbers of flinches that occurred during the first ( Fig. 2a , arrow). KDEL receptor interaction with KDELtagged proteins is optimal at acidic pH; therefore, the minute of each 5-min interval up to 70 min were measured.
localization of KDEL receptor staining and mRFP KDEL is limited. The ERD2 staining pattern was similar to that In order to determine whether transplanted cells can produce detectable levels of engineered peptides in the described previously (39) . In Figure 2b , the red signal from mRFP KDEL and green signal from cytochrome c spinal CSF, we initiated evaluation of spinal CSF samples following cell transplantation. In preliminary stud-(long green line in the x-axis) did not overlap, suggesting that the mRFP KDEL was absent in mitochondria. Nu-ies, 100-150 µl of CSF was collected by aspiration from the subarachnoid cavity of the spinal cord at the level of clei visualized with DAPI suggested that mRFP KDEL was also not translocated into the nucleus (Fig. 2c ). the foramen magnum 2 weeks following transplantation. 
Anti-SHG Immunostaining of Cells Transduced Evidence for SHG Synthesis and Processing by Confocal Microscopy With SHG Lentivirus
There is no commercial source for anti-histogranin Based on published literature, the NGF-β signal sequence directs the polypeptide into the regulated secre-or anti-serine histogranin antibodies; therefore, a custom antibody for SHG was generated for us with 21st Cen-tory pathway (RSP). In TGN the polypeptide would be cleaved by furin, cathepsin L, and carboxypeptidases to tury Biochemicals. A synthetic SHG peptide was used to immunize rabbits. Anti-SHG antibody showed a dose-release SHG but retain mRFP KDEL , via interaction with the KDEL receptors (3,43). dependent reaction with the synthetic SHG peptide (Fig.  3a) . Densitometric scanning of the blots showed that
Confocal imaging was used to visualize the separation of the SHG-mRFP KDEL polypeptide into SHG and anti-SHG signal fades proportionately with twofold decreasing concentration of the SHG peptide (y-axis) and mRFP KDEL . The 293T cells, which have flat morphology, were used for this evaluation. Following transduction with the anti-SHG antibody dilution (x-axis). The specificity of the reaction is supported by the lack of reaction with "red SHG lentivirus," cells were fixed and stained for SHG (43) . Upon imaging by confocal microscopy of anti-SHG antibody (high titers) with an irrelevant peptide, endomorphin-1 (EM-1) (Fig. 3a, lane 4) . diffuse perinuclear yellow fluorescence and punctate red and green fluorescence could be observed (Fig. 3b ). sults were obtained in PC12 cells ( Fig. 3c ) and two different types of human bone marrow stromal cells ( Fig.  Based on previous experiments the sole source of red fluorescence is mRFP KDEL , while that for green fluores-3d, e). cence is Alexa 488 anti-rabbit antibody that is bound to Secretion of SHG From Transduced Cells anti-SHG antibody. The yellow fluorescence results from combined red and green fluorescent signals. The pres-
The above data suggest that SHG-mRFP KDEL was properly processed and mRFP KDEL appropriately local-ence of diffuse yellow-orange fluorescence indicates freshly synthesized, as yet unprocessed, SHG-mRFP KDEL ized; the following experiments address the fate of secretable peptide SHG. To assay secretion of SHG, cul-polypeptide (asterisk). The location of diffuse yelloworange fluorescence is consistent with the location of ture supernatants of naive PC12 cells and "red SHG" lentivirus transduced PC12 cells were analyzed using endoplasmic reticulum and Golgi at the base of the nucleus. A graphic representation of fluorescence intensi-dot blotting. Assays are shown from PC12 cells that had been maintained for 17 months in vitro in order to con-ties along a line (white line drawn left to right) across the image was used to visualize processing of "SHG-firm stable expression of the transgene. The dot-blotted membranes were probed with anti-SHG antibody and mRFP KDEL " polypeptide. Care was taken to avoid imaging artifacts: (i) the fluorescence signals were ac-developed using standard protocols. Only the "red SHG" lentivirus transduced PC12 supernatants contained SHG quired by setting exposure at subsaturating levels, (ii) as an internal control, the line was drawn outside the cell (Fig. 4a) . Further, to test how much of total cellular encoded SHG is secreted, we compared the SHG content (between 35 and 50 µm from start) and the fluorescence signals in that region are very low and correspond to released into the supernatants with cell lysates. Densitometric scanning of dot blots revealed that ϳ42% of the background. An asterisk in the image marks the diffuse yellow fluorescence region that arises due to overlap-intracellular SHG is secreted into the supernatant over a 3-day period (Fig. 4b) . In order to verify that dot blot-ping red (mRFP KDEL ) and green (SHG) signals (0-20 µm from start in the profile, lower panel). The cluster of red ting was detecting authentic SHG peptides, the supernatants were collected, analyzed on a gradient Tris-tricine puncta (at ϳ25 µm) corresponds to multiple mRFP KDEL "red-only" peaks. A single green peak (at 30 µm from SDS-PAGE, and blotted (Fig. 4c) . The blots probed with anti-SHG antibody showed a specific band in the ex-start) corresponds to "SHG-only" signal. These distinct red and green peaks correspond to processed peptide pected range. The synthetic peptide SHG (ϳ2 kDa) can be seen in first lane. The SHG band is absent in lanes (i.e., "cellular label" mRFP KDEL and SHG). Similar re- 
containing the protein ladder (second lane) and naive
Biological Activity of Recombinant SHG From Transplanted Cells PC12 culture supernatants (third lane). The SHG band of slightly higher molecular weight (ϳ3 kDa) can be seen to increase in the "red SHG" PC12 culture superna-Cerebrospinal fluids from rats that received SHG secreting or control PC12 cells (500,000/rat) were ana-tants over various collection times (3, 6, and 10 days). A band of similar size was seen from PC12 cell cultures lyzed by dot blots and Western blots. SHG was detected in the CSF from animals that received SHG-secreting that had been transduced to express SHG alone (Fig. 4c , last lane). Blots were stripped and reprobed with anti-cells ( Fig. 5, upper panel lane 6) , compared with control PC12 cell-transplanted animals (lane 5). Examples from mRFP antibody. No signal corresponding to mRFP KDEL could be detected (data not shown). similarly transduced bovine chromaffin cells (RedSHG BCC) are also shown (lanes 2-4). These have not been DISCUSSION evaluated yet in behavioral models due to insufficient quantities obtained thus far. Western blots confirmed the
The study was an initial attempt to produce transplantable cells that can retain genetic labeling and the ϳ2 kDa SHG band as the source of the signal in dot blots (Fig. 5a, lower panel) . Taken together these results ability to secrete novel potential analgesic peptides such as SHG, a peptide that is not naturally occurring. Several suggest that the recombinant DNA encoded SHG is secreted specifically by cells transduced with either SHG recombinant DNA strategies are available to produce expression of two transgenes. Among these, dual pro-or "red SHG" lentiviruses. The recombinant SHG secreted by PC12 cells seems to be of slightly higher mo-moter-based vectors, bicistronic vectors with viral internal ribosomal entry sites (IRES), and self-cleaving lecular weight than the synthetic SHG.
To test if the secreted recombinant SHG possessed peptide-based vectors have been used (2, 22, 27, 38) . Due to the limited capacity of lentiviral vectors, use of dual biological activity from transplanted cells, rats with either naive PC12 cells or "red SHG" transduced PC12 promoter vectors is a viable option only when transgenes are short. The IRES-based system has many draw-cell transplants were tested using a standard formalin test. Briefly, the animals receive a formalin injection in backs when used in a lentiviral context. IRES-driven second gene expression in a lentiviral construct often the hind paw, and rate of paw flinching indicate extent and duration of pain (12) . The tonic phase (phase 2) is fails or is poor; variables such as gene composition and arrangement need to be optimized (6, 20, 37, 44, 45) . The thought to be initiated by activation of NMDA receptors as it is suppressed by NMDA antagonists including self-cleaving peptide mechanism is not well understood, and it is not possible to predict whether certain post-chemically synthesized SHG (17, 35) . Compared to the naive group, the "red SHG" group showed a modest re-translational modifications required for analgesic peptide biological activity would be negatively impacted duction in hind paw flinching in response to formalin injection during phase 2 (p < 0.05) (Fig. 5b, c) . (14, 38) . In initial studies in our laboratory, we found a signifi-polypeptide, in a similar fashion to endogenous preproenkephalin, which is synthesized as a single polypeptide cant reduction of IRES-driven EGFP expression within weeks of lentiviral transduction (not shown), rendering and enzymatically processed into bioactive peptide enkephalins. Our construct contains a ppNGF-β signal se-this approach unusable for long-term expression studies. Fluorescent protein fusions are often used to monitor quence followed by a furin cleavage site RSKR, SHG cDNA, a cathepsin L cleavage site (dipeptide lysine and gene expression. However, tagging SHG (a 14-amino acid peptide) with a bulky fluorescent protein (ϳ300 arginine, KR), and KDEL-tagged mRFP. The recombinant protein would be cotranslationally inserted into ER amino acids), or even the smallest labels such as hexahistidine tag (19) , could interfere with SHG biological via ppNGF-β signal sequence. Despite being KDEL tagged, it is not expected to be retrieved by Erd2 until function and activity. Thus, we sought a novel approach to overcome these drawbacks, and SHG and the "cellu-it reaches the acidic environment in trans-Golgi. Our data indicate that in such acidic environments, the three lar label" were designed to be synthesized as a single activities of furin, cathepsin L, and Erd2 process poly-this cell type compared with normal chromaffin cells. Compared to the culture supernatants, the amount of peptide into secretable SHG and intracellular mRFP KDEL (30) . Furin and KDEL receptors are known to colocalize peptide SHG in CSF is low due to lower number of transplanted cells. (9), and KDEL receptors retrieve KDEL-terminated proteins in acidic pH all the way from TGN (16, 26) . Furin
In summary, these findings are an initial step in the generation of genetically labeled transplantable cells for cleaves only in the acidic environment of TGN. Following cleavage from signal peptide in TGN, mRFP KDEL is delivery of novel analgesic molecules. Taken together, these data suggest that genetic modification of cells to retrieved from TGN by the KDEL receptors.
Some KDEL-terminated proteins are found on the secrete biologically active analgesic peptides, while retaining identification markers, is a viable approach for cell surface also (4,42). KDEL-terminated proteins such as viral, bacterial, and plant toxins enter cells in a two-transplantation. In addition, the simplicity of the design of the interchangeable construct should allow for substi-step process: (a) endocytosis followed by (b) KDEL receptor-mediated shuttling from TGN to ER is well docu-tution and insertion of other potent natural or synthetic analgesic peptides or combinations that can be tailored mented (36) . This route has been exploited to transport even KDEL-tagged oligonucleotides into the ER (31).
for the treatment of chronic pain of different etiologies. This may be a mechanism by which cells could take mic reticulum (1,5,28).
Consistent with previous work showing that the REFERENCES CMV promoter-driven signal peptide containing RFP K-DEL was not localized to endosomes, lysosomes, or mito-
